Allergan Receives Third “Approvable” Letter For Combigan In Intraocular Pressure
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is counting on a confirmatory trial initiated in 2005 to satisfy FDA concerns regarding the glaucoma treatment.
You may also be interested in...
Allergan Eyes Posurdex Approval In Late 2007
The company also pursuing potential macular degeneration indication.
Inspire To Submit Additional Data For Dry Eye Treatment
Ongoing discussions between the company and FDA regarding diquafosol may take several months, Inspire says.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.